Pharmacoeconomic analysis of paliperidone palmitate for treating schizophrenia in Greece

Pharmacoeconomic analysis of paliperidone palmitate for treating schizophrenia in Greece

<p>Abstract</p> <p>Background</p> <p>Patients having chronic schizophrenia with frequent relapses and hospitalizations represent a great challenge, both clinically and financially. Risperidone long-acting injection (RIS-LAI) has been the main LAI atypical antipsychotic...

Full description

Bibliographic Details
Main Authors: Einarson Thomas R, Geitona Maria, Chaidemenos Alexandros, Karpouza Vasiliki, Mougiakos Theodoros, Paterakis Periklis, Ploumpidis Dimitrios, Potamitis-Komis Dionyssios, Zilbershtein Roman, Vicente Colin, Piwko Charles, Kakkavas Panagiotis, Paparouni Konstantina, Jensen Rasmus C D, Hemels Michiel E H
Format: Article
Language:English
Published: BMC 2012-07-01
Series:Annals of General Psychiatry
Subjects:
Paliperidone palmitate
Risperidone
Long-acting injectables
Schizophrenia
Pharmacoeconomic analysis
Greece
Online Access:http://www.annals-general-psychiatry.com/content/11/1/18

Internet

http://www.annals-general-psychiatry.com/content/11/1/18

Similar Items